Trump floated the idea of an Australian-inspired retirement system overhaul. Experts are skeptical it'd improve Social ...
Since its debut 25 years ago, the Summer Film Academy has consistently offered local students access to film education and ...
Years ago, LSD was seen as the evil stepchild of drugs. Today, research indicates LSD may treat anxiety and depression, and ...
Todd Thompson has been the go-to person in Indiana for geologic information about all the basic societal needs tied to this ...
The State Duma at the plenary session approved in the first reading the government's draft basic law on support for the ...
By RIO YAMAT, AP Airlines and Travel Writer. They may arrive at the same destination, but two passengers on the same flight ...
Ministry of Science and ICT, KOFST and overseas Korean associations discuss AI-driven research collaboration and global ...
Korea Joongang Daily on MSN
Regulator set to rein in leveraged ETFs tied to Samsung, SK hynix amid wild volatility
Authorities are preparing tougher rules as a surge in buying and selling fuels massive swings in the main bourse, with one ...
Ten years after its launch, Vision 2030 remains Saudi Arabia's roadmap for resilience. The Iran war reinforced—not ...
With the country celebrating the 250th anniversary of the Declaration of Independence this week, Washington College faculty ...
Two asteroid encounters by Japan and China reveal new clues about small worlds, sample returns, and future planetary defense.
Zacks Small Cap Research on MSN
OTC Markets Life Sciences Investor Forum: Dan Teleman, CEO, and Eyal Rubin, SVP and CFO, of Nasus Pharma with Zacks SCR's John Vandermosten, CFA
NYSE: NSRX Lily: Hello, and welcome to the Life Sciences Investor Forum. On behalf of OTC Markets and our co-host, Zacks Small Cap Research, we are very pleased you have joined us. The next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results